Pyomyositis Presenting As Myonecrosis Secondary to Methicillin-resistant Bacteremia in Chronic Lymphocytic Leukemia

Overview

Journal Proc (Bayl Univ Med Cent)

Specialty General Medicine

Date 2022 Aug 22

PMID 35991747

Authors

Shannon Coombs

Albert Bui

Haares S Mirzan

Kimberly Robelin

Hillary W Garner

Murli Krishna

Jennifer B Cowart

Affiliations

Soon will be listed here.

Abstract

The incidence of pyomyositis in immunocompromised patients with HIV, diabetes, myelodysplastic syndromes, and acute lymphocytic leukemia is well documented. However, there are only a few reports of pyomyositis and myonecrosis in patients with chronic lymphocytic leukemia (CLL). We present a rare case of pyomyositis presenting as myonecrosis secondary to methicillin-resistant eus bacteremia in a 72-year-old patient with CLL. Pyomyositis, although rare, warrants increased provider awareness and management, especially among CLL patients who pose diagnostic and treatment challenges.

References

Scarfo L, Ferreri A, Ghia P . Chronic lymphocytic leukaemia. Crit Rev Oncol Hematol. 2016; 104:169-82. DOI: 10.1016/j.critrevonc.2016.06.003. View

Montazeri N, Athale U, Fulford M, Tarnopolsky M . Pyomyositis Causing Temporary Quadriparesis During Induction Therapy for Acute Lymphoblastic Leukemia: Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2014; 37(3):223-6. DOI: 10.1097/MPH.0000000000000161. View

Pinelli F, Cecero E, DeglInnocenti D, Selmi V, Giua R, Villa G . Infection of totally implantable venous access devices: A review of the literature. J Vasc Access. 2018; 19(3):230-242. DOI: 10.1177/1129729818758999. View

White M, Morgan R, Drazer M, Eng O . Gastrointestinal Surgical Emergencies in the Neutropenic Immunocompromised Patient. J Gastrointest Surg. 2021; 25(12):3258-3264. PMC: 8665083. DOI: 10.1007/s11605-021-05116-9. View

Sharma A, Kumar S, Wanchu A, Sharma K, Sharma N, Singh R . Clinical characteristics and predictors of mortality in 67 patients with primary pyomyositis: a study from North India. Clin Rheumatol. 2009; 29(1):45-51. PMC: 7101911. DOI: 10.1007/s10067-009-1277-x. View

Fukushima T, Iwao H, Nakazima A, Miki M, Sakai T, Sawaki T . MRSA-pyomyositis in a patient with acute myelogenous leukemia after intensive chemotherapy. Anticancer Res. 2009; 29(8):3361-4. View

Andersen M, Eriksen C, Brieghel C, Biccler J, da Cunha-Bang C, Helleberg M . and predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study. Haematologica. 2018; 103(7):e300-e303. PMC: 6029543. DOI: 10.3324/haematol.2017.182006. View

Andersen M, Moser C, Lundgren J, Niemann C . Epidemiology of bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal nation-wide cohort study. Leukemia. 2018; 33(3):662-670. DOI: 10.1038/s41375-018-0316-5. View

Gordon B, Martinez S, Collins A . Pyomyositis: characteristics at CT and MR imaging. Radiology. 1995; 197(1):279-86. DOI: 10.1148/radiology.197.1.7568838. View

10.

Yu C, Hsiao J, Hsiao J, Hsu C, Shih T . Bacterial pyomyositis: MRI and clinical correlation. Magn Reson Imaging. 2004; 22(9):1233-41. DOI: 10.1016/j.mri.2004.08.005. View

11.

Stevens D, Bisno A, Chambers H, Dellinger E, Goldstein E, Gorbach S . Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014; 59(2):147-59. DOI: 10.1093/cid/ciu296. View

12.

Singh P, Chan W, Blomfield P, McIntosh R . Pyomyositis after chemotherapy for endometrial cancer. Int J Gynecol Cancer. 2011; 20(7):1256-8. DOI: 10.1111/IGC.0b013e3181ecb562. View

13.

Casciola-Rosen L, Hall J, Mammen A, Christopher-Stine L, Rosen A . Isolated elevation of aldolase in the serum of myositis patients: a potential biomarker of damaged early regenerating muscle cells. Clin Exp Rheumatol. 2012; 30(4):548-53. PMC: 3786178. View

14.

Jolissaint J, Harary M, Saadat L, Madenci A, Dieffenbach B, Al Natour R . Timing and Outcomes of Abdominal Surgery in Neutropenic Patients. J Gastrointest Surg. 2019; 23(4):643-650. DOI: 10.1007/s11605-018-04081-0. View

15.

Crum N . Bacterial pyomyositis in the United States. Am J Med. 2004; 117(6):420-8. DOI: 10.1016/j.amjmed.2004.03.031. View

16.

Brook I . Microbiology and management of myositis. Int Orthop. 2004; 28(5):257-60. PMC: 3456972. DOI: 10.1007/s00264-004-0578-6. View

17.

Habeych M, Trinh T, Crum-Cianflone N . Purulent infectious myositis (formerly tropical pyomyositis). J Neurol Sci. 2020; 413:116767. DOI: 10.1016/j.jns.2020.116767. View

18.

Maravelas R, Melgar T, Vos D, Lima N, Sadarangani S . Pyomyositis in the United States 2002-2014. J Infect. 2020; 80(5):497-503. DOI: 10.1016/j.jinf.2020.02.005. View

19.

Hengstman G . Isolated elevated aldolase as a marker for a myositis subtype: another branch to the polymyositis tree. J Neurol Neurosurg Psychiatry. 2009; 80(8):829. DOI: 10.1136/jnnp.2009.174052. View

20.

Andersen M, Rostgaard K, Niemann C, Hjalgrim H . Antimicrobial use before chronic lymphocytic leukemia: a retrospective cohort study. Leukemia. 2020; 35(3):747-751. DOI: 10.1038/s41375-020-0980-0. View